For the first time, standards have been developed detailing the best practice treatments for all types of breast cancer to ensure that every New Zealander gets the best possible care.
You now have the opportunity to comment on these standards and BCAC is urging you to do so. Your input could play a part in improving breast cancer care for women yet to be treated.
The Boobops Breast Cancer Dragon Boat Team have capped off an amazing season winning their third consecutive National title win at the New Zealand Dragon Boat Association National Championships held at the Blue Lakes Rotorua on Saturday 6th April.
A huge thanks to everyone who got in behind BCAC's annual fundraiser, Show Your Heart for Women Living with Breast Cancer, which ran between April 22 and May 19.
In particular, we'd like to acknowledge the support of Arnott's Tim Tam, Woman's Day magazine and Countdown supermarkets.
Breast cancer has dealt Angela Litterick-Biggs a death sentence. But the Wellington woman refuses to accept defeat and lives her life with an energy and passion that’s truly extraordinary.
It was Angela Litterick-Biggs’ worst birthday ever. On the day she turned 41, only a couple of years after her mother died of cancer, Angela was told she had breast cancer.
Around 150 women under the age of 40 will be diagnosed with breast cancer in New Zealand each year and these women face many concerns that their older counterparts do not have to confront.
BCAC committee member Greer Davis understands these issues all too well. She is one of the 150 - she was diagnosed with breast cancer last year at the age of only 25.
Researchers have for the first time calculated by how much radiation therapy for breast cancer increases the risk of heart disease and the findings can now be used by doctors to help treat patients more appropriately.
The research, by scientists at the University of Oxford and in Scandinavia and published in the New England Journal of Medicine, looked at more than 2,000 women treated with radiation therapy in Denmark and Sweden.
Getting through breast cancer treatment can unleash a whole new set of emotions for many women.
You may be elated at finishing treatment, apprehensive about the lack of contact with medical professionals, scared about a recurrence of the cancer, or fearless about what the future holds.
UK scientists have discovered a number of genes which are responsible for developing resistance to a targeted medicine used in the treatment of HER2-Positive breast cancer.
The team at the Institute of Cancer Research in London examined a number of genes that were overactive in women with HER2 Positive breast cancer who had developed a resistance to the drug Lapatinib (Tykerb).
BCAC applauds the latest figures from BreastScreen Aotearoa, which show that more Pasifka women are going for regular mammograms than ever before.
A new study shows that there’s been a small, but significant increase in the incidence of advanced breast cancer in young American women aged 25 to 39, without a corresponding increase in older women.
